Correction: A Challenge for the Development of Malaria Vaccines: Polymorphic Target Antigens
نویسنده
چکیده
The text of the Acknowledgments section was incomplete. It should have read: “We acknowledge the use of the Neisseria Multi Locus Sequence Typing Web site (http://pubmlst.org/neisseria) developed by Keith Jolley and Man-Suen Chan and sited at the University of Oxford. The development of this site has been funded by the Wellcome Trust and European Union. We are grateful for support and contributions of E. Arnold, F. Binka, S. Droz, I. Ehrhard, B. Genton, and M. Tanner. In the Navrongo Health Research Center, we greatly appreciate the assistance of A. Bugri, S. Abudulai, and A. Wahab in the laboratory; all nurses and health workers in the War Memorial Hospital, Navrongo and the Health Centers of the KND; C. Tindana with all fi eld workers and drivers for excellent work in the fi eld; and T. Tei and M. Bugase for logistic support. We acknowledge the use of the Navrongo Demographic Surveillance System database, and we thank all study participants for their trust and contribution.”
منابع مشابه
Designing malaria vaccines to circumvent antigen variability✩
Prospects for malaria eradication will be greatly enhanced by an effective vaccine, but parasite genetic diversity poses a major impediment to malaria vaccine efficacy. In recent pre-clinical and field trials, vaccines based on polymorphic Plasmodium falciparum antigens have shown efficacy only against homologous strains, raising the specter of allele-specific immunity such as that which plague...
متن کاملIdentification of Pre-Erythrocytic Malaria Antigens That Target Hepatocytes for Killing In Vivo and Contribute to Protection Elicited by Whole-Parasite Vaccination
Pre-erythrocytic malaria vaccines, including those based on whole-parasite approaches, have shown protective efficacy in animal and human studies. However few pre-erythocytic antigens other than the immunodominant circumsporozoite protein (CSP) have been studied in depth with the goal of developing potent subunit malaria vaccines that are suited for use in endemic areas. Here we describe a nove...
متن کاملA Malaria Vaccine Based on the Polymorphic Block 2 Region of MSP-1 that Elicits a Broad Serotype-Spanning Immune Response
Polymorphic parasite antigens are known targets of protective immunity to malaria, but this antigenic variation poses challenges to vaccine development. A synthetic MSP-1 Block 2 construct, based on all polymorphic variants found in natural Plasmodium falciparum isolates has been designed, combined with the relatively conserved Block 1 sequence of MSP-1 and expressed in E.coli. The MSP-1 Hybrid...
متن کاملTargets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity.
Plasmodium falciparum is the major cause of malaria globally and is transmitted by mosquitoes. During parasitic development, P. falciparum-infected erythrocytes (P. falciparum-IEs) express multiple polymorphic proteins known as variant surface antigens (VSAs), including the P. falciparum erythrocyte membrane protein 1 (PfEMP1). VSA-specific antibodies are associated with protection from symptom...
متن کاملTransmission blocking malaria vaccines: Assays and candidates in clinical development.
Stimulated by recent advances in malaria control and increased funding, the elimination of malaria is now considered to be an attainable goal for an increasing number of malaria-endemic regions. This has boosted the interest in transmission-reducing interventions including vaccines that target sexual, sporogenic, and/or mosquito-stage antigens to interrupt malaria transmission (SSM-VIMT). SSM-V...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- PLoS Medicine
دوره 4 شماره
صفحات -
تاریخ انتشار 2007